Concord Biotech Limited (BOM:543960)
1,199.15
-22.40 (-1.83%)
At close: Mar 2, 2026
-19.80% (1Y)
| Market Cap | 125.63B |
| Revenue (ttm) | 11.59B |
| Net Income (ttm) | 3.13B |
| Shares Out | n/a |
| EPS (ttm) | 29.69 |
| PE Ratio | 40.20 |
| Forward PE | 30.96 |
| Dividend | 10.70 (0.89%) |
| Ex-Dividend Date | Sep 3, 2025 |
| Volume | 50,613 |
| Average Volume | 123,020 |
| Open | 1,166.40 |
| Previous Close | 1,221.55 |
| Day's Range | 1,166.40 - 1,224.95 |
| 52-Week Range | 1,056.75 - 2,149.90 |
| Beta | n/a |
| RSI | 49.52 |
| Earnings Date | Feb 11, 2026 |